Empagliflozin
Who holds supplier records for Empagliflozin? 44 organisations hold a current record for Empagliflozin: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (30), China (8), Spain (1), Netherlands (1) and 1 other country (1); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Empagliflozin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/empagliflozin
Reading the evidence
- 44 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
30 of the 41 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 21 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Empagliflozin expires 11 Dec 2034. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (44)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Empagliflozin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 32349, 32477, 43731 +2 · latest filing Mar 2026
- HONOUR LAB LTDIndia Company GMP cert on recordActive DMF 40332, 32534, 31523 · latest filing Oct 2024
- EMNAR PHARMA PRIVATE LTDIndiaActive DMF 36742, 41237 · latest filing Jan 2025
- Mankind Pharma LimitedIndia Company GMP cert on recordActive DMF 41404, 40847 · latest filing Sept 2025
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 32161, 32662 · latest filing May 2018
- Zhejiang Huahai Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 37867, 32385 · latest filing Dec 2022
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 43815, 32378 · latest filing Mar 2026
- AARTI PHARMALABS LIMITEDIndiaActive DMF 42587 · latest filing Sept 2025
- Alembic Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 32211 · latest filing Nov 2017
- ALP PHARM BEIJING CO LTDActive DMF 29796 · latest filing Sept 2015
- AMI LIFESCIENCES PRIVATE LTDIndia Company GMP cert on recordActive DMF 38200 · latest filing Mar 2023
- AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)IndiaActive DMF 41025 · latest filing Dec 2024
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 32454 · latest filing Jan 2018
- AZICO BIOPHORE INDIA PVT LTDIndiaActive DMF 40742 · latest filing Dec 2024
- BEIJING HUIKANG BOYUAN CHEMICAL TECH CO LTDChinaActive DMF 29801 · latest filing Oct 2015
- Biocon LimitedIndiaActive DMF 36477 · latest filing Nov 2021
- CHEMO SMS ENTERPRISE SLSpainActive DMF 39157 · latest filing Nov 2023
- Cipla LimitedIndia Company GMP cert on recordActive DMF 32433 · latest filing Mar 2018
- COHANCE LIFESCIENCES LTDIndia Company GMP cert on recordActive DMF 36944 · latest filing Jul 2022
- Ctx LifesciencesIndiaActive DMF 42918 · latest filing Dec 2025
- FUXIN LONG RUI PHARMACEUTICAL CO LTDActive DMF 33100 · latest filing Sept 2018
- Granules India LimitedIndia Company GMP cert on recordActive DMF 39521 · latest filing Mar 2024
- HIKAL LTDIndia Company GMP cert on recordActive DMF 32570 · latest filing Sept 2018
- Jiangxi Synergy Pharmaceutical Co., LtdChinaActive DMF 37622 · latest filing Nov 2022
- Laurus Labs LimitedIndia Company GMP cert on recordActive DMF 32881 · latest filing Jun 2018
- LEE PHARMA LTDIndia Company GMP cert on recordActive DMF 36162 · latest filing Aug 2022
- LUPIN MANUFACTURING SOLUTIONS LTDActive DMF 31501 · latest filing Apr 2017
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 32392 · latest filing Jan 2018
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 31087 · latest filing Oct 2016
- METROCHEM API PRIVATE LTDIndiaActive DMF 35345 · latest filing Oct 2020
- MOREPEN LABORATORIES LTDIndia Company GMP cert on recordActive DMF 33931 · latest filing Jul 2019
- Neuland Laboratories LimitedIndiaActive DMF 41197 · latest filing Jan 2025
- OPTIMUS DRUGS PRIVATE LTDIndiaActive DMF 39776 · latest filing Mar 2024
- Piramal Pharma LimitedIndia Company GMP cert on recordActive DMF 33545 · latest filing Mar 2019
- Sichuan Kelun Pharmaceutical Co., Ltd.ChinaActive DMF 40416 · latest filing Sept 2024
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 32601 · latest filing May 2018
- SYMBIO GENERRICS INDIA PRIVATE LTDIndiaActive DMF 42317 · latest filing Jun 2026
- TAPI NL BVNetherlandsActive DMF 32421 · latest filing Sept 2018
- USV PRIVATE LTDIndia Company GMP cert on recordActive DMF 39318 · latest filing Dec 2023
- YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTDChinaActive DMF 41748 · latest filing Apr 2025
- Zakłady Farmaceutyczne Polpharma S.A.Poland Company GMP cert on recordActive DMF 33180 · latest filing Sept 2018
- Zhejiang Huayi Pharmaceutical Co., Ltd.ChinaActive DMF 37755 · latest filing Dec 2022
- Zhejiang Jingsheng Pharmaceutical Co., Ltd.ChinaActive DMF 39603 · latest filing Mar 2024
- Zhejiang Langhua Pharmaceutical Co. Ltd.ChinaActive DMF 36541 · latest filing Dec 2021
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (4 listed products contain Empagliflozin). The latest listed patent expires 11 Dec 2034. The latest listed exclusivity runs to 20 Dec 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor used in the treatment of type 2 diabetes. It helps lower blood sugar levels by preventing glucose reabsorption in the kidneys, promoting its excretion.
Chemical identity
- IUPAC name
- (2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
- Canonical SMILES
- C1COC[C@H]1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl
- InChIKey
- OBWASQILIWPZMG-QZMOQZSNSA-N
- Synonyms
- bi-10773, bi10773, glyxambi component empagliflozin, jardiance, trijardy xr component empagliflozin
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Sodium-Glucose Cotransporter 2 Inhibitor
- Mechanism of action
- Sodium-Glucose Transporter 2 Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Empagliflozin?
44 organisations hold an active US FDA Type II Drug Master File or a CEP for Empagliflozin: Dr. Reddy's Laboratories Ltd. (India), HONOUR LAB LTD (India), EMNAR PHARMA PRIVATE LTD (India), Mankind Pharma Limited (India), MSN LIFE SCIENCES PRIVATE LIMITED (India), Zhejiang Huahai Pharmaceutical Co., Ltd. (China), Zydus Lifesciences Limited (India) and AARTI PHARMALABS LIMITED (India), and 36 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Empagliflozin Drug Master Files are active?
Dr. Reddy's Laboratories Ltd. (DMF 32349, 32477), HONOUR LAB LTD (DMF 40332, 32534), EMNAR PHARMA PRIVATE LTD (DMF 36742, 41237), Mankind Pharma Limited (DMF 41404, 40847), MSN LIFE SCIENCES PRIVATE LIMITED (DMF 32161, 32662), Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 37867, 32385), Zydus Lifesciences Limited (DMF 43815, 32378) and AARTI PHARMALABS LIMITED (DMF 42587) and 36 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does the FDA Orange Book list patents for products containing Empagliflozin?
Yes. The latest patent listed for an approved US product containing Empagliflozin expires 11 Dec 2034, across 4 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Empagliflozin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Empagliflozin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.